Pharmabiz

MOC’s first neighbourhood cancer treatment facility inaugurated in Delhi

MOC’s first neighbourhood cancer treatment facility inaugurated in Delhi: Our Bureau, Mumbai Monday, December 8, 2025, 14:45 ...
Pharmabiz

Viatris to get to $400 mn in cash and $415 mn in equity shares of Biocon as it inks pact to monetise its equity stake

Viatris to get to $400 mn in cash and $415 mn in equity shares of Biocon as it inks pact to monetise its equity stake: Our Bureau, Bengaluru Monday, December 8, 2025, 17:30 Hrs [I ...
Pharmabiz

Biocytogen’s partner Ideaya Biosciences receives US FDA clearance to initiate phase 1 trial of IDE034, a potential first-in-class B7H3/ PTK7 bispecific ADC

Biocytogen’s partner Ideaya Biosciences receives US FDA clearance to initiate phase 1 trial of IDE034, a potential first-in-class B7H3/ PTK7 bispecific ADC: Beijing Monday, Dece ...
Pharmabiz

OS Therapies announces US FDA PDUFA waiver & EMA grants Union Marketing Authorisation eligibility for OST-HERs

OS Therapies announces US FDA PDUFA waiver & EMA grants Union Marketing Authorisation eligibility for OST-HERs: New York Monday, December 8, 2025, 16:00 Hrs [IST] OS Therapies Inc ...
Pharmabiz

BorderPlus extends footprint to Saudi Arabia and the GCC to build global pathways for healthcare professionals

BorderPlus extends footprint to Saudi Arabia and the GCC to build global pathways for healthcare professionals: Our Bureau, Mumbai Monday, December 8, 2025, 17:15 Hrs [IST] In ord ...
Pharmabiz

Lumov raises $1.2 mn seed round from Incubate Fund Asia & others to redefine orthopaedic recovery and rehabilitation in India

Lumov raises $1.2 mn seed round from Incubate Fund Asia & others to redefine orthopaedic recovery and rehabilitation in India: Our Bureau, Bengaluru Monday, December 8, 2025, 16:1 ...
Pharmabiz

HRV Pharma bags Great Place To Work Status for 2025–2026, underscoring trust and inclusivity at the workplace

HRV Pharma bags Great Place To Work Status for 2025–2026, underscoring trust and inclusivity at the workplace: Our Bureau, Bengaluru Monday, December 8, 2025, 14:30 Hrs [IST] HR ...
Pharmabiz

Sophos report reveals 58% of providers now recover within a week amid declining ransom payments

Sophos report reveals 58% of providers now recover within a week amid declining ransom payments: Our Bureau, Mumbai Monday, December 8, 2025, 16:50 Hrs [IST] Sophos, a global lead ...
Pharmabiz

SSO secures $2.8 million in funding from the Everhope Oncology platform to accelerate its next phase of growth

SSO secures $2.8 million in funding from the Everhope Oncology platform to accelerate its next phase of growth: Our Bureau, Bengaluru Monday, December 8, 2025, 14:15 Hrs [IST] Spe ...
Pharmabiz

Replicate Bioscience & Instituto Butantan ink collaboration to develop and commercialize Replicate’s srRNA rabies vaccine in Latin America

Replicate Bioscience & Instituto Butantan ink collaboration to develop and commercialize Replicate’s srRNA rabies vaccine in Latin America: San Diego, California Monday, Decembe ...
Pharmabiz

Indo–Italian medical consensus sounds alarm on paediatric sarcoma; experts urge action on early diagnosis

Indo–Italian medical consensus sounds alarm on paediatric sarcoma; experts urge action on early diagnosis: Our Bureau, Bengaluru Monday, December 8, 2025, 13:40 Hrs [IST] IndoIt ...
Pharmabiz

Trivitron unveils its Digital.AI to propel hospital digitization and clinical interoperability in India

Trivitron unveils its Digital.AI to propel hospital digitization and clinical interoperability in India: Our Bureau, Bengaluru Monday, December 8, 2025, 16:20 Hrs [IST] Trivitron ...